Literature DB >> 9458417

Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population.

T A McDonagh1, M Woodward, C E Morrison, J J McMurray, H Tunstall-Pedoe, G D Lowe, K E McColl, H J Dargie.   

Abstract

AIM: Recent evidence suggests that Helicobacter pylori infection is associated with coronary heart disease. We investigated whether H. Pylori infection is related to prevalent coronary heart disease, in a random sample of 1428 men and women aged 25-74 years. METHODS AND
RESULTS: Coronary heart disease was assessed by questionnaire and electrocardiography (ECG). Standard risk factors for coronary heart disease, fibrinogen concentration and serum concentrations of H. pylori-specific IgG antibody were measured. H. pylori seropositivity increased with age (P < or = 0.001) and was significantly more prevalent in men than women. H. pylori infection was associated with current smoking and a higher systolic blood pressure in men but not in women. There was no significant increase in the odds ratio in those seropositive for H. pylori with regard to any manifestation of coronary heart disease, after adjustment for age, standard cardiovascular risk factors and social class. Likewise, age-adjusted plasma fibrinogen was no higher in seropositives.
CONCLUSION: Seropositivity to H. pylori is associated with a trend towards a greater prevalence of coronary heart disease. However, that association is likely to be spurious and can be adequately explained by the much stronger association of H. pylori infection with age and social class, both of which are linked with coronary heart disease.

Entities:  

Mesh:

Year:  1997        PMID: 9458417     DOI: 10.1093/oxfordjournals.eurheartj.a015436

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  11 in total

Review 1.  Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosis.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies.

Authors:  J Danesh; R Peto
Journal:  BMJ       Date:  1998-04-11

3.  Is there an association between Helicobacter pylori infection and coronary heart disease?

Authors:  R Pellicano; I Mladenova; N Broutet; L R Salmi; F Mégraud
Journal:  Eur J Epidemiol       Date:  1999-08       Impact factor: 8.082

4.  Seasonal variations in out of hospital cardiopulmonary arrest.

Authors:  J P Pell; J Sirel; A K Marsden; S M Cobbe
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

5.  Ectasia and severe atherosclerosis: relationships with chlamydia pneumoniae, helicobacterpylori, and inflammatory markers.

Authors:  Ali K Adiloglu; Rabia Can; Cem Nazli; Ahmet Ocal; Oktay Ergene; Gulgun Tinaz; Nesimi Kisioglu
Journal:  Tex Heart Inst J       Date:  2005

Review 6.  Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.

Authors:  Traci L Testerman; James Morris
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

7.  Seroprevalence of antibodies to microorganisms known to cause arterial and myocardial damage in patients with or without coronary stenosis.

Authors:  C Stöllberger; G Mölzer; J Finsterer
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

8.  Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction.

Authors:  M Gunn; J C Stephens; J R Thompson; B J Rathbone; N J Samani
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

Review 9.  Emerging relations between infectious diseases and coronary artery disease and atherosclerosis.

Authors:  I W Fong
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

10.  The Role of Helicobacter pylori and NSAIDs in the Pathogenesis of Uncomplicated Duodenal Ulcer.

Authors:  Ayhan Hilmi Cekin; Muharrem Taskoparan; Adil Duman; Cem Sezer; Yesim Cekin; Basak Oguz Yolcular; Hasan Can; Fatma Seher Pehlivan; Mine Cayirci
Journal:  Gastroenterol Res Pract       Date:  2012-09-25       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.